Xiidra Approved; Pending Effective Date

Posted in Latest News on September 14, 2016.

At the August 19, 2016 Board of Optometry meeting, the board voted and approved the use of Xiidra (Lifitegrast ophthalmic solution 5%) for dry eyes. The formulary rule is in the process of being changed to include Lifitegrast ophthalmic solution 5%.

Until the new rule becomes effective, Florida Optometrists are not allowed to prescribe the medication. The board will place a notification on the website advising when the addition to the rule has become effective.



More Latest News

Florida Jurisprudence CE Requirement
February 11, 2019

The Board of Optometry voted to waive the 2-hour Florida Jurisprudence requirement for all out-of-state licensees for the current biennium only. Click Here for more information. Continue reading


Important Notice Regarding Inveltys
February 11, 2019

The Board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002, F.A.C. Formulary of Topical Ocular Pharmaceutical Agents Continue reading